Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Covalon Tech Ltd (TSV: COV )

3.350 +0.115 (+3.55%)
Streaming Delayed Price Updated: 3:59 PM EDT, Sep 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,395
Open 3.280
Bid (Size) 3.250 (3)
Ask (Size) 3.350 (1)
Prev. Close 3.235
Today's Range 3.280 - 3.350
52wk Range 0.9600 - 3.460
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST
Via ACCESSWIRE
Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference
From Covalon Technologies Ltd.
Via Business Wire

Performance

YTD
+170.16%
+170.16%
1 Month
+6.35%
+6.35%
3 Month
+59.52%
+59.52%
6 Month
+179.17%
+179.17%
1 Year
+123.33%
+123.33%

More News

Read More
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
From Covalon Technologies Ltd.
Via Business Wire
Covalon Announces First Quarter Fiscal 2024 Results
From Covalon Technologies Ltd.
Via Business Wire
Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing
From Covalon Technologies Ltd.
Via Business Wire
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
From Covalon Technologies Ltd.
Via Business Wire
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
From Covalon Technologies Ltd.
Via Business Wire
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective
From Covalon Technologies Ltd.
Via Business Wire
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
From Covalon Technologies Ltd.
Via Business Wire
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
From Covalon Technologies Ltd.
Via Business Wire
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
From Covalon Technologies Ltd.
Via Business Wire
Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida
From Covalon Technologies Ltd.
Via Business Wire
Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon
From Covalon Technologies Ltd.
Via Business Wire
Breakthrough Solution for Fragile Skin: Covalon’s IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of Excellence
From Covalon Technologies Ltd.
Via Business Wire
Covalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023
From Covalon Technologies Ltd.
Via Business Wire
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
From Stock News Now
Via AccessWire
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
From Stock News Now
Via AccessWire
Covalon Technologies to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021
From Covalon Technologies Ltd.
Via AccessWire
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.